Fidia S.p.A. (BIT:FDA)
0.0084
0.00 (0.00%)
Aug 13, 2026, 3:39 PM CET
Fidia Employees
Fidia had 146 employees as of December 31, 2025. The number of employees decreased by 13 or -8.18% compared to the previous year.
Employees
146
Change
-13
Growth
-8.18%
Revenue / Employee
€209,329
Profits / Employee
€7,116
Market Cap
4.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 146 | -13 | -8.18% |
| Jun 30, 2025 | 140 | - | - |
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | - | - |
| Jun 30, 2020 | 289 | -42 | -12.69% |
| Mar 31, 2020 | 299 | -32 | -9.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Danieli & C. Officine Meccaniche | 9,952 |
| Biesse | 3,601 |
| SIT S.p.A. | 1,916 |
| Tesmec | 929 |
| ILPRA | 422 |
| Marzocchi Pompe | 249 |
| OSAI Automation System | 222 |
| Clabo | 148 |
Fidia News
- 2 hours ago - Sagimet Biosciences Gets FDA Clearance For Phase 3 Acne Study - Nasdaq
- 4 hours ago - Belite Bio Q2 Net Loss Widens; FDA Sets PDUFA Date For Tinlarebant In February 2027 - Nasdaq
- 9 hours ago - SPRO Looks 14.8% Overvalued on GF Value⢠as FDA Approval Spurs Interest - GuruFocus
- 13 hours ago - Exelixis (EXEL) Q2 2026 Earnings Call Transcript - The Motley Fool
- 13 hours ago - Inovio (INO) Q2 2026 Earnings Call Transcript - The Motley Fool
- 14 hours ago - OraSure (OSUR) Q2 2026 Earnings Call Transcript - The Motley Fool
- 17 hours ago - Revolution Medicines (RVMD) Q2 2026 Earnings Call Transcript - The Motley Fool
- 19 hours ago - Arbutus Advances Imdusiran; FDA Aligns On Phase 2b Trial Design - Nasdaq